Cure My Disease

Don't miss your cure!

 Log in / Sign up

Frailty score may reveal hidden risks for young septic shock patients

NCT ID NCT05928767

Knowledge-focused Sponsor: Centre Hospitalier de Lens Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether frailty—measured by a simple scale—can predict death in adults aged 18 to 65 admitted to intensive care for septic shock. Researchers will track 200 patients to see if those who are frail have a higher risk of dying within 28 days, even after accounting for other factors. The goal is to help doctors and families make better decisions about care intensity and expectations.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors better predict outcomes for younger septic shock patients and tailor care intensity based on frailty.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly change patient care. Results may not apply to all ICU settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2023

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients admitted to intensive care will be studied for this study. Patients meeting the inclusion criteria and with no non-inclusion criteria will be included in the study after obtaining the patient's or relative's, if applicable, non-objection.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged ≥18 years and ≤ 65 years * Patient admitted to intensive care - resuscitation * Patient admitted for suspected or documented type 3 sepsis * Presence of vasopressor amines to maintain MAP \> 65mmHg despite filling * Lactatemia ≥ 2 mmol/L on admission. Exclusion Criteria: * Patient moribund on admission * Patients with severe pre-existing dementia and/or cognitive decline, suffering from severe neurodegenerative diseases that prevent the patient from living independently at baseline, including mental illness requiring institutionalisation, including acquired or congenital mental retardation, etc. * Pregnant women or women in labour * Patients under guardianship or curatorship * Patients deprived of their liberty * Patient and/or family unable to speak or understand French.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Frailty are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Frailty Septic shock

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CH Boulogne sur Mer

    RECRUITING

    Boulogne-sur-Mer, 62321, France

  • CH de Lens

    RECRUITING

    Lens, France

  • CHU Lille

    RECRUITING

    Lille, 59037, France

  • CHU de Dijon

    RECRUITING

    Dijon, 21079, France

  • Ch Germon Et Gauthier

    RECRUITING

    Béthune, 62408, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.